Thyroid cancer survival statistics

Survival

Survive thyroid cancer for 10 or more years, 2009-2013, England

 

Age

Age that thyroid cancer survival is highest, 2009-2013, England

 

90% of men survive thyroid cancer for at least one year, and this is predicted to fall to 82% surviving for five years or more, as shown by age-standardised Open a glossary item net survival for patients diagnosed with thyroid cancer during 2009-2013 in England.[1] Survival for women is higher, with 94% surviving for one year or more, and 91% predicted to survive for at least five years.

Thyroid Cancer (C73), Age-Standardised One-, Five- and Ten-Year Net Survival, Adults (Aged 15-90), England, 2009-2013

1-Year Survival (%) 5-Year Survival (%) 10-Year Survival (%)
Men Net Survival 90.0 82.3 75.3
95% LCL 88.8 80.4 66.8
95% UCL 91.0 84.1 82.0
Women Net Survival 93.9 91.3 88.5
95% LCL 93.3 90.4 86.8
95% UCL 94.4 92.1 89.9
Adults Net Survival 92.8 88.9 85.0
95% LCL 92.3 88.1 82.4
95% UCL 93.3 89.6 87.2

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item
 
Five- and ten-year survival is predicted using an excess hazard statistical model
 

In men, thyroid cancer survival is similar at five and ten years after diagnosis. In women, thyroid cancer continues to fall beyond five years. 75% of men and 89% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with thyroid cancer during 2009-2013 in England.[1]

Survival for thyroid cancer is reported in Scotland and Wales,[2,3] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses.

References

  1. Muller P, Belot A, Morris M, Rachet B, Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine. Net survival and the probability of cancer death from rare cancers. Available from http://csg.lshtm.ac.uk/rare-cancers/. Accessed July 2016.
  2. ISD Scotland. Trends in Cancer Survival 1983-2007.
  3. Welsh Cancer Intelligence and Surveillance Unit. Cancer in Wales: 2001-2004.
Last reviewed:

Five-year survival for thyroid cancer is highest in the youngest men and women and decreases with increasing age. Five-year net survival in men ranges from 96% in 15-49 year olds to 40% in 80-99 year-olds for patients diagnosed with thyroid cancer in England during 2009-2013.[1] In women, five-year survival ranges from 99% to 51% in the same age groups.

Thyroid Cancer (C73), Five-Year Net Survival by Age, England, 2009-2013

References

  1. Muller P, Belot A, Morris M, Rachet B, Cancer Research UK Cancer Survival Group, London School of Hygiene and Tropical Medicine. Net survival and the probability of cancer death from rare cancers. Available from http://csg.lshtm.ac.uk/rare-cancers/. Accessed July 2016.
Last reviewed:

Five-year relative survival for thyroid cancer in men in England (77%) Wales (74%), Scotland (75%) and Northern Ireland (69%) are below the average for Europe (81%).[1] Across the European countries for which data is available, five-year relative survival in men ranges from 61% (Latvia) to 90% (Iceland).[1

Five-year relative survival for thyroid cancer in women in England (83%) is below the average for Europe (88%). Wales (78%) is also below the European average but Scotland (84%) and Northern Ireland (84%) are similar to the European average.[1] Across the European countries for which data is available, five-year relative survival in women ranges from 77% (Ireland) to 95% (Croatia).[1

Thyroid Cancer (C73.9), Age-Standardised Five-Year Relative Survival, Adults (Aged 15+), European Countries, 2000-2007

Data consists of both observed and predicted 5-year relative survival. Where sufficient follow-up was not available for recently diagnosed patients the period approach was used to predict 5-year cohort survival.

Possible explanations for persistent international differences in survival include differences in cancer biology, use of diagnostic tests and screening, stage at diagnosis, access to high-quality care, and data collection practices.[1]

References

  1. De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5 a population-based study. Lancet Oncol 2014;15:23-34

About this data

Data is for: 29 European countries, patients diagnosed in 2000-2007 and followed up to 2008, thyroid gland cancer (C73.9).

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Rate this page:

Currently rated: 1.4 out of 5 based on 7 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page